Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid LeukemiaJay P. Patel, Ross L. Levine, Agnès Viale et al.|New England Journal of Medicine|2012Cited by 1.9k
Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignanciesOmar Abdel‐Wahab, Ross L. Levine, Ann Mullally et al.|Blood|2009Cited by 718
Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell CarcinomaJames J. Hsieh, Robert J. Motzer, David Chen et al.|European Urology|2016Cited by 204
Molecular and clinical presentation of <i>UBA1</i>-mutated myelodysplastic syndromesMaria Sirenko, Joop H. Jansen, Elsa Bernard et al.|Blood|2024Cited by 53
Identification of efficacy biomarkers in a large metastatic renal cell carcinoma (mRCC) cohort through next generation sequencing (NGS): Results from RECORD-3.James J. Hsieh, Robert J. Motzer, David Chen et al.|Journal of Clinical Oncology|2015Cited by 26